Beyond Air, Inc. (XAIR) Tops Q4 EPS by 2c

Go back to Beyond Air, Inc. (XAIR) Tops Q4 EPS by 2c

Beyond Air Reports Financial Results for Fiscal Fourth Quarter and Year-End 2020

June 22, 2020 4:01 PM EDT

Reported positive clinical data for third bronchiolitis study using high concentration nitric oxide, achieving primary and key secondary endpoints

Enrolled first patient in the U.S. COVID-19 study using the LungFit system

Announced positive pre-clinical data validating high concentration nitric oxide as a potential treatment for ablating solid tumors and inducing an anti-tumor immune response

PMA for the LungFit... More